The document is an intimation of a revision to an Analyst/Investor Conference Call schedule, filed pursuant to SEBI Listing Regulations (Regulation 30).
The event is a post-results conference call scheduled to discuss the company's business strategy and outlook following the declaration of its Q2 FY27 Unaudited Financial Results.
The revised date and time is Thursday, 5th November 2026, at 2:30 PM Indian Standard Time (IST). This is a change from the previously communicated time of 4:00 PM IST.
The call will feature six management participants:
Mr. Mohan Goenka – Wholetime Director & Vice Chairman
Mr. Vivek Dhir – CEO (International Business)
Mr. Dhruv Aggarwal – Chief Growth Officer
Mr. Gul Raj Bhatia – President (Healthcare)
Mr. Manish Gupta – President (Sales)
Mr. Rajesh Sharma – President (Finance & IR)
The purpose of the call is explicitly stated as a discussion of the company's "business strategy and outlook."
The event is scheduled after the declaration of the Q2 FY27 unaudited financial results.
Detailed dial-in information is provided for universal access in India (+91 22 6280 1259 / +91 22 7115 8160) and toll-free numbers for international participants from the USA (18667462133), UK (08081011573), Singapore (8001012045), and Hong Kong (800964448).
The announcement includes a compliance reference to SEBI LODR Regulations, indicating this is a formal regulatory disclosure.
Additional Notes Section
The document is a follow-up to a previous letter dated 26th October 2026.
The details of the conference call are stated to be enclosed with the letter.
The information will also be available on the company's website at the provided URL: https://www.emamiltd.in/investors/stock-exchange-filings/schedule-of-investor/.
Contact information for further details is provided for Percy Panthaki and Siddhesh Deshmukh of IIFL Capital.
No financial data, results, guidance, or strategic details beyond the event's purpose are disclosed in this announcement.
